fluvoxamine

(redirected from Luvox CR)
Also found in: Medical.

flu·vox·a·mine

 (flo͞o-vŏk′sə-mēn′)
n.
A drug of the SSRI class, C15H21O2N2F3, used in its maleate form primarily to treat obsessive-compulsive disorder.

[flu(oro)- + valero-, containing valeric acid + ox(y)- + amine.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

fluvoxamine

(fluːˈvɒksəmiːn)
n
(Pharmacology) an antidepressant drug that acts by preventing the re-uptake after release of serotonin in the brain, thereby prolonging its action. See SSRI
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
Mentioned in ?
References in periodicals archive ?
Previously, Horton worked with Solvay Pharmaceuticals and Abbott Laboratories, leading the approval efforts for key products including, Androgel Stickpack, Creon Capsules and Luvox CR Capsules.
Its marketed products include Xyrem (sodium oxybate), Erwinaze (asparaginase Erwinia chrysanthemi), Prialt (ziconotide) intrathecal infusion, FazaClo (clozapine USP) HD and LD and Luvox CR (fluvoxamine maleate).
Net sales of once-daily Luvox CR (fluvoxamine maleate) were USD7.3m for the second quarter of 2011, compared to USD5.8m for the prior year period, a rise of 26% in annual terms.